| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $70.3M | +149.9% |
| SG&A Expense | $29.5M | +185.1% |
| Income Tax | $0 | — |
| Net Income | -$96.6M | -150.9% |
| EPS (Basic) | -$1.66 | +83.6% |
| EPS (Diluted) | -$1.66 | +83.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.3M | -77.9% |
| Short-term Investments | $138.1M | — |
| Current Assets | $200.4M | -27.2% |
| Total Assets | $200.6M | -27.1% |
| Current Liabilities | $20.4M | +127.8% |
| Total Liabilities | $20.4M | +127.8% |
| Stockholders' Equity | $180.2M | -32.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.0M | -95.0% |
| Investing Cash Flow | -$137.0M | — |
| Financing Cash Flow | -$397K | -100.1% |